๐จ When it rains, it pours! ๐จ
Three peer-reviewed studies just came out, further validating #MeMedBV. Highlights include:
63% reduction in unnecessary antibiotics & fewer hospitalizations outperforming standard of care
See: https://t.co/24PmbDIT1I
#AMR#Sepsis#Hostresponse
Excited to welcome an extraordinary group of experts to join MeMed โs advisory team!
Dave Hickey, a leader in the IVD industry,
Dr. David Shulkin, former U.S. Secretary of Veterans Affairs
Prof. Beat Mรผller, pioneer in sepsis care
for more see: https://t.co/ZNNgt33YfI
Another significant milestone! MeMed has attained #IVDR certification by the notified body TรV SรD for commercialization of #MeMedBVยฎ in Europe under the new EU regulations.
Big thanks to Olga, Eli, Sharon, Harel, Sally, Efrat and the rest of the MeMeds that made this happen.
๐ข MeMed continues to enhance its Board of Directors with the addition of Scott Garrett. Scottโs addition further bolsters our leadership team after welcoming @OHadomi and Peter Scheu.
https://t.co/vPvEegWAJW
Excited to share NEW study published in Pediatrics, enrolling >2,000 children, showing high performance of MeMed BV in distinguishing bacterial vs viral infections. Another step towards better-informed treatment decisions to fightย #amr
Full article: https://t.co/6X0NQLjnQA
@memeddx@ESCMID@EU_Commission New study published in journal Clinical Microbiology and Infection finds high performance of MeMed BV in elderly patients with Lower Respiratory Tract infections. Another important milestone in the fight against #AMR & making MeMed BV part of routine care https://t.co/YBzckbltCM
โจ๏ธโจ๏ธโจ๏ธMeMed BV's remarkable accuracy in diagnosing bacterial/viral LRTI in adults regardless of age, comorbidities (including #COPD) or PCR results. Outperformed CRP & PCT in differentiating bacterial/viral infections. #MedTech@ESCMID@EU_Commission https://t.co/XuZ1XChV81
Join us next week as we discuss using MeMed BVยฎ in patients with suspected acute infection, with Dr. Adi Klein, Head of Pediatrics at Hillel Yaffe Medical Center in Hadera, Israel.
Register Now https://t.co/7jO2FcYF1y
#AMR#AntibioticResistance
Honored to be named among โFierce 15โ Medtech Companies of the year. Congrats to the fantastic @memeddx team!
Find out more at: https://t.co/tBiiXKBB1A
Lots of chatter after Biden's comments re. social media's impact on mental health.
Is social media the 21st century tobacco? Should it be regulated?
Re-upping this from last year:
Antimicrobial resistance โ the Silent Pandemic doesnโt receive much PR. But it has become a leading cause of death worldwide, potentially much larger than HIV and malaria. A recent Lancet paper is yet another wakeup call:
https://t.co/j62uh1NL2Y
We're pleased to announce that we have successfully closed a $93M financing round to scale up manufacturing, accelerate commercialization and expand our pioneering host immune response product portfolio.
Read the press release: https://t.co/ONOt7UWXbW
#IDTwitter#HostResponse
The closing of over $90M financing round represents a significant milestone for @memeddx. Congratulations to #TeamMeMed for all the hard work!
https://t.co/4og1bqYPAm
Thrilled to share that FDA cleared the first technology to distinguish between bacterial and viral infections using the bodyโs immune response - our very own #MeMed BV test and #MeMed Key platform. Itโs been a decade long journey and the best is yet to come... exciting times!
BREAKING NEWS! MeMed BVยฎ and MeMed Keyยฎ have been granted FDA clearance. FDA clears the first technology of its kind to distinguish between bacterial and viral infections using the bodyโs immune response. Read the full press release here: https://t.co/pr1FEXGOaP
#fdacleared
Join Professor of Pharmacy, Infectious Diseases Pharmacist, Dr. Debra Goff, at the Presentation Theater at IDWEEK alongside MeMed CEO, Eran Eden, on September 16, 12:00- 1:00 pm EDT
https://t.co/3h7wF5TGjR
An exciting day for @memeddx ! Our #hostresponse test MeMed COVID-19 Severityโข has received the CE mark. Many thanks to our incredible team & collaborators globally for helping us achieve this milestone! #COVID19